Has Guensley Delva, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,093 in general payments to Guensley Delva, MD across 508 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Guensley Delva, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Guensley Delva, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Guensley Delva, MD

Interventional Pain Medicine · Waycross, GANPI 1285019018

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Boston Scientific at 25.0% of the total. 2025 is the largest year on record at $10,107, more than ten times the $554 reported in 2020. Among interventional pain medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,093in general payments, 2019–2025

Across 508 payments — averaging $73.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$9K
Medtronic$7K
Abbott$3K
Saluda Medical Americas, Inc.$3K
Painteq LLC$3K
Relievant Medsystems, Inc.$2K
plus $11K from 15 others

What the payments were for

Travel & lodging$16,99446%
Food & beverage$18,50650%
Education$1,5934%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	129	$9,282
Medtronic(2 entities)	130	$6,731
Abbott	31	$2,775
Saluda Medical Americas, Inc.	13	$2,623
Painteq LLC	20	$2,602
Relievant Medsystems, Inc.	18	$2,404
Nalu Medical, Inc.	29	$2,163
Nevro Corp.	35	$1,976
Spinal Simplicity, LLC	22	$1,864
Si-bone, Inc.	11	$1,254
SPR Therapeutics, Inc	20	$1,039
Curonix LLC	16	$822
Stimwave Technologies Incorporated	10	$685
Vertos Medical, Inc.	10	$298
Stryker	1	$175
MML US, Inc.	3	$164
GRT US Holding, Inc.	3	$108
Forte Bio-pharma LLC	2	$45
Collegium Pharmaceutical, Inc.	2	$35
Globus Medical	2	$34
Convatec Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,093 in reported general payments places this provider in the 90th percentile of 129 interventional pain medicine providers in Georgia.

See all interventional pain medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$177,814

Medicare patients

201

Services billed

2,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	342	$10,143
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	177	$5,119
Lidocaine	46	$3,670
Gabapentin	147	$1,480
Pregabalin	62	$906
Tizanidine Hcl	105	$823
Morphine Sulfate ErMorphine Sulfate	27	$443
Diclofenac Sodium	23	$422
Celecoxib	23	$360
Cyclobenzaprine Hcl	26	$278
Cephalexin	45	$265
Oxycodone Hcl	23	$265
Acetaminophen-CodeineAcetaminophen With Codeine	21	$231
Methocarbamol	39	$227
Mupirocin	15	$151

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Waycross

Emmanuel GageBrunswick$602K
Jordan TateJasper$540K
Christopher BovinetBrunswick$338K
David RosenfeldCovington$249K
Nathan NeufeldNewnan$171K
Ryan BudwanyLawrenceville$123K
Alexandra MoreiraAtlanta$79K
Sushanth BodaNewnan$55K
Christopher AndrianoStockbridge$41K
Richard EpterAugusta$31K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →